Abstract
The primary replication protein, HPV E1, has been shown to play a role in mitigating host defence and disrupting normal cell cycle processes, leading to the development of cancer. This study investigated the expression profile of HPV16 E1 in various stages of cervical cancer development and the factors that control E1 expression. One hundred and twenty-four HPV16-positive cervical samples ranging from normal to CIN 1, CIN 2/3, and SCC lesions were studied. E1 mRNA expression was determined by ddPCR. Methylation of promoters p97 and p670 was quantified by pyrosequencing, while PCR, qPCR, and sequencing were used to determine the physical state and variations of the HPV16 E1 genome. Increased E1 mRNA expression related to disease progression (normal 0.18, CIN 1 0.41, CIN 2/3 0.65, and SCC 0.79) was demonstrated with a significant positive correlation (r = 0.661, p = 0.019). No association between physical state and E1 expression was found. Methylation of p97 and p670 promoters showed significant elevation in SCC compared to normal samples. Only 4.2% showed genomic variations of HPV16 E1 63-bp duplication. E1 may play a role in cancer development. The detection of E1 mRNA and promoter methylation may be useful as cancer prognostic...Continue Reading
References
Nov 7, 1998·The Journal of Biological Chemistry·J S LiuL T Chow
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Dec 26, 2001·Oncogene·F Mantovani, L Banks
Mar 7, 2002·Journal of Clinical Microbiology·Shoji NagaoTakafumi Kudo
Mar 7, 2002·Journal of Clinical Microbiology·Panu PeitsaroStina Syrjänen
May 10, 2002·Cancer·Feng Wang-JohanningGary L Johanning
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Jan 30, 2004·Journal of Virology·Yueh-Ming Loo, Thomas Melendy
Jan 18, 2006·Journal of Virology·Randolph V ClowerThomas Melendy
Oct 19, 2006·Journal of Virological Methods·Mangalathu S RajeevanElizabeth R Unger
Dec 2, 2008·Journal of Medical Virology·Ivan SabolMagdalena Grce
Mar 25, 2010·Cancer Research·John P MaufortPaul F Lambert
Feb 15, 2011·Future Virology·Vonetta M WilliamsPenelope J Duerksen-Hughes
Jun 15, 2011·Molecular and Cellular Probes·Markus SchmittMichael Pawlita
Jul 8, 2011·Journal of Virology·Amélie Fradet-TurcotteJacques Archambault
Jul 8, 2011·Journal of Virology·Nozomi SakakibaraAlison A McBride
Jul 20, 2011·The Open Virology Journal·C M D'Abramo, J Archambault
Apr 12, 2012·Journal of Virology·Iris CornetUNKNOWN IARC HPV Variant Study Group
Apr 17, 2012·Lancet·J FerlayF Bray
May 10, 2012·Genes & Development·Jason R BurkeSeth M Rubin
Oct 16, 2012·International Journal of Cancer. Journal International Du Cancer·Arkom ChaiwongkotMagnus von Knebel Doeberitz
Sep 14, 2013·Virology·Monika BergvallJacques Archambault
Oct 10, 2013·Journal of Molecular Biology·Jason R BurkeSeth M Rubin
Oct 2, 2014·Journal of Translational Medicine·Rong ZhangLong Yu
Oct 10, 2014·Open Biology·Andres CastilloSuminori Akiba
Jan 8, 2015·Journal of Clinical Pathology·Sankhadeep DuttaChinmay Kumar Panda
Feb 5, 2015·Journal of Medical Virology·Tsin-Wah LeungHextan Y S Ngan
Dec 15, 2015·Virology·Maria FedorovaNatalia Kisseljova
Jun 25, 2016·Viruses·Molly L BristolIain M Morgan
Nov 20, 2016·Virus Research·Samuel S PorterAlison A McBride
Jul 21, 2017·Intervirology·Eskandar TaghizadehSeyed Mohammad Gheibi Hayat
Citations
Sep 22, 2019·Scientific Reports·Leonardo Josué Castro-MuñozMarcela Lizano
Nov 28, 2018·Infectious Agents and Cancer·Miaomiao MaRuozheng Wang
Jun 15, 2019·Viral Immunology·Alfredo Amador-MolinaMarcela Lizano
Sep 2, 2021·PloS One·Arkom ChaiwongkotParvapan Bhattarakosol
Dec 31, 2021·PloS One·Fern BaedyanandaParvapan Bhattarakosol